ALKBH3-mediated m1A demethylation promotes the malignant progression of acute myeloid leukemia by regulating ferroptosis through the upregulation of ATF4 expression
To investigate the role of ALKBH3 in acute myeloid leukemia (AML), we constructed an animal model of xenotransplantation of AML. Our study demonstrated that ALKBH3-mediated m1A demethylation inhibits ferroptosis in KG-1 cells by increasing ATF4 expression, thus promoting the development of AML. Thes...
Saved in:
Main Authors: | Xin Liu, Xinghua Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Hematology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2025.2451446 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ALKBH1: emerging biomarker and therapeutic target for cancer treatment
by: Ming Zhu Xiao, et al.
Published: (2024-12-01) -
ALKBH5-mediated m6A demethylation of Runx2 mRNA promotes extracellular matrix degradation and intervertebral disc degeneration
by: Yu Lei, et al.
Published: (2024-06-01) -
Sodium aescinate-induced hepatotoxicity via ATF4/GSH/GPX4 axis-mediated ferroptosis
by: Chen Xi, et al.
Published: (2025-01-01) -
ALKBH5 alleviates lower extremity arteriosclerosis by regulating ITGB1 demethylation and influencing macrophage polarization
by: Zeyu Guan, et al.
Published: (2025-01-01) -
Regulation and therapy: the role of ferroptosis in DLBCL
by: Yifan Wang, et al.
Published: (2025-01-01)